Summer New Zealand Equities fund performance summary as at 30 April 2021.
Unit price (as at 30 April 2021): $1.6879
Date the fund started: 19 September 2016
For information on fees, see our Fees page.
See the New Zealand Equities page for the Summary of investment objective and strategy.
|PIR||Total since inception (annualised)||1 Month||3 Month||1 Year||3 Years^|
Fund returns are calculated net of fund charges, trading expenses and accrued tax for a New Zealand resident individual paying tax at the Prescribed Investor Rate identified above.
|Asset name||% of fund net assets|
|1||Fisher & Paykel Healthcare Corporation Limited||11.09%|
|2||Spark New Zealand Limited||6.73%|
|3||Contact Energy Limited||6.08%|
|5||Fletcher Building Limited||5.32%|
|6||The a2 Milk Company Limited||5.31%|
|7||Ebos Group Limited||4.56%|
|8||Meridian Energy Limited||4.49%|
|9||ANZ transactional bank account||4.38%|
The top 10 investments make up 58.05% of the fund.
The next Manager’s commentary will be included in the June Performance Summary (available July 2021).
This is not a recommendation to buy or sell any financial product and does not take your personal circumstances into account. All opinions reflect our judgement on the date of communication and may change without notice. Past performance is not a reliable guide to future performance. We recommend you take financial advice before making investment decisions. We have prepared this web page in good faith based on information obtained from other sources, but we do not guarantee the accuracy of that information. We do not make any representation or warranty (express or implied) that this web page is accurate, complete, or current and to the maximum extent permitted by law disclaim any liability for loss which may be incurred by any person relying on this web page.